Evidence map›Paper›PMID 32559113›Full record

ReviewThe British journal of radiology2020

Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging.

Nicolò Gennaro, Andrea Marrari, Salvatore Lorenzo Renne, Ferdinando Carlo Maria Cananzi, Vittorio Lorenzo Quagliuolo, Lucia Di Brina, Marta Scorsetti, Giovanna Pepe, Arturo Chiti, Armando Santoro and 3 more

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Molecular imaging and radionuclide therapy · 2023
    Article
  5. Article
  6. Article
  7. GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  8. Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT.European journal of nuclear medicine and molecular imaging · 2021
    Article
  9. Article
  10. Metabolic response as assessed byCancer medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicolò GennaroDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.ORCID http://orcid.org/0000-0001-7259-6980
Andrea MarrariDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Salvatore Lorenzo RenneDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Ferdinando Carlo Maria CananziDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Vittorio Lorenzo QuagliuoloSarcoma, Melanoma and Rare Tumors Surgery Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Lucia Di BrinaDept. of Radiation Oncology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Marta ScorsettiDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Giovanna PepeDept. of Nuclear Medicine, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Arturo ChitiDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Armando SantoroDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Luca BalzariniDept. of Radiology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Letterio Salvatore PolitiDept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Alexia Francesca BertuzziMedical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhabdomyosarcoma (RMS) represents more than 50% of paediatric soft tissue tumours. Conversely, it is extremely rare among adults, where it shows peculiar biological and clinical features that are still poorly investigated. RMS patients should be referred to a Sarcoma Centre, where the contribution of experienced radiologists plays a relevant role in the diagnostic assessment of the disease, including precise localisation, staging, image-guided biopsy, response evaluation after treatment and follow-up. Besides CT and MRI, hybrid imaging including positron emission tomography (PET)/CT and PET/MRI are giving an increasing contribution to provide functional insights about tumour biology and to improve the diagnostic accuracy of the imaging work-up. This review paper provides a revision of the pathology, clinical and radiological features of adult RMS, with a particular focus on the growing role of hybrid PET-based imaging.

Indexed as

Multimodal ImagingHumansMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyRhabdomyosarcomaSoft Tissue NeoplasmsTomography, X-Ray Computed

Identifiers

PMID32559113
PMCPMC7446015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.